Table 8

SES differences in choice of providers for the treatment of malaria


Inyi
Udi
Oji
Nachi

n (%)
n (%)
n (%)
n (%)

Home treatment




Q1: most poor
0 (0)
2 (25.0)
4 (80.0)
2 (33.3)
Q2:average
6 (50.0)
6 (75.0)
0 (0)
2 (33.3)
Q3: least poor
6 (50.0)
0 (0)
1 (20.0)
2 (33.3)
Chi square (p-value)
6.3 (0.04)
6.4 (0.04)
4.6 (0.10)
2.1 (0.7)
Concentration index
0.34
-0.84
-
0.01

Traditional medicines




Q1: most poor
8 (32.0)
3 (100.0)
6 (75.0)
10 (31.3)
Q2:average
9 (36.0)
0 (0)
1 (12.5)
6 (18.7)
Q3: least poor
8 (32.0)
0 (0)
1 (12.5)
16 (50.0)
Chi square (p-value)
0.05 (0.9)
10.1 (0.01)
5.3 (0.07)
5.1 (0.08)
Concentration index
-0.08
-
-
0.13

Private hospital




Q1: most poor
14 (44.8)
2 (12.5)
6 (46.1)
3 (16.7)
Q2:average
6 (18.7)
4 (25.0)
5 (38.5)
6 (33.3)
Q3: least poor
12 (37.5)
10(62.5)
2 (15.4)
9 (50.0)
Chi square (p-value)
4.2 (0.1)
4.8 (0.09)
1.05 (0.6)
3.0 (0.2)
Concentration index
-0.04
0.33
-0.19
0.23

Public hospital




Q1: most poor
2 (14.3)
5 (31.3)
1 (25.0)
1 (33.3)
Q2:average
7 (50.0)
8 (50.0)
2 (50.0)
1 (33.3)
Q3: least poor
5 (35.7)
3 (18.7)
1 (25.0)
1 (33.3)
Chi square (p-value)
2.8 (0.3)
3.1 (0.2)
.39 (.82)
0.01 (0.9)
Concentration index
0.15
0.12
-
-

Patent medicine dealer




Q1: most poor
33 (36.7)
9 (25.7)
13 (35.1)
21 (41.1)
Q2:average
30 (33.3)
12 (34.3)
11 (29.8)
19 (37.3)
Q3: least poor
27 (30.0)
14 (40.0)
13 (35.1)
11 (21.6)
Chi square (p-value)
1.1 (0.6)
0.4 (0.8)
4.1 (0.39)
7.7 (0.02)
Concentration index
-0.05
0.10
0.01
-0.11

Primary Healthcare (PHC) centre




Q1: most poor
0 (0)
0 (0)
0 (0)
0 (0)
Q2:average
1 (33.3)
0 (0)
1 (100)
1 (100)
Q3: least poor
2 (66.3)
1 (100)
0 (0)
0 (0)
Chi square (p-value)
2.1 (0.4)
1.6 (0.4)
1.6 (0.5)
2.2 (0.3)
Concentration index
-
-
-
-

Onwujekwe et al. Malaria Journal 2008 7:5   doi:10.1186/1475-2875-7-5